Real-time enrollment status for this moderate to severe atopic dermatitis clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 9:49 AM UTC
| NCT Number | NCT07558668 |
| Recruiting Status | Recruiting |
| Condition | Moderate to Severe Atopic Dermatitis |
| Phase | Clinical Trial |
| Target Enrollment | 149 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Sitryx Therapeutics Ltd |
| Last Updated on CT.gov | April 30, 2026 (Apr 30, 2026) |
As of July 13, 2026: Clinical trial NCT07558668 is currently recruiting participants. This clinical trial study for moderate to severe atopic dermatitis is actively seeking new participants at 6 locations across the United States. The study is sponsored by Sitryx Therapeutics Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07558668 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07558668 was last updated Apr 30, 2026 (April 30, 2026). HelloStudys verifies this status automatically.